-
Document de presse | 2025.04.28
HIV: genetic characteristics associated with sustained HIV remission after stopping treatment
Tackling HIV continues to be a major public health challenge, mainly because the persistence of viral reservoirs means that people living with HIV need to take lifelong antiretroviral treatment. But some individuals, known as "post-treatment controllers," are able to maintain an undetectable viral load even after stopping treatment. In a study funded by ANRS Emerging Infectious Diseases (ANRS...
-
News | 2025.05.19
Institut Pasteur To Host International Meeting on Mirror Biology
The Institut Pasteur will host an international conference on June 12-13, 2025 addressing the potentially unprecedented risks of mirror life, organized in partnership with the Mirror Biology Dialogues Fund. The conference marks the first in a series of global meetings planned throughout 2025 and 2026 to explore pathways for research and policy to mitigate the potential risks of mirror life.
-
News | 2025.05.30
Deep Tech Venture Builder: the project PICASSO from the Institut Pasteur joins EIT Health program
Specifically designed to support academic teams with deep tech solutions, EIT Health’s DTVB provides start-ups with the right support to overcome the most frequent hurdles experienced when launching to market. Notoriously known as the “Valley of Death” – where many promising ideas fail to transition out of academic environments – successfully navigating this stage requires overcoming the most...
-
News | 2025.05.30
Institut Pasteur deploys MinoSuiteTM “Pioneer” platform from startup Minos Biosciences, developing next-generation cell analysis technology
With the deployment of its MinoSuiteTM Pioneer platform at the Institut Pasteur, within the Dynamics of Host-Pathogen Interactions unit, headed by Dr. Jost Enninga, deep-tech startup Minos Biosciences has officially launched its Early Access Program. The strategic collaboration between Minos Biosciences and the teams of Jost ENNINGA and Milena HASAN from the Institut Pasteur, partially funded by...
-
Article | 2019.02.22
PPU-Oxford Program
"Chimie Biologique"Linking Chemistry and Microbiology to Fight Human Diseases
-
Vidéo | 2025.06.02
Dive into the heart of an infection
An exceptional dive into the heart of a cell infected by Shigella, the bacterium responsible for dysentery.How does a bacterium manage to infiltrate our cells and cause a serious illness? Using cutting-edge imaging techniques, Léa SWISTAK, a former researcher in Jost Enninga's laboratory at the Institut Pasteur, takes us behind the scenes of a cellular infection.This spectacular visual dive...
-
Document de presse | 2025.06.04
Vigilance and targeted public health measures are essential in the face of the diphtheria epidemic that has affected vulnerable populations in Western Europe since 2022
A study published in the New England Journal of Medicine (NEJM) reveals that the largest diphtheria epidemic in Western Europe for 70 years, which broke out in 2022 among migrants and in 2023 spread to other vulnerable populations in several European countries, is the result of contaminations occurring during migratory travel or in destination European countries, and not in the countries of...
-
Document de presse | 2025.05.29
The plague bacillus became less virulent, prolonging the duration of two major pandemics
Scientists at the Institut Pasteur and McMaster University have discovered that the evolution of a gene in the bacterium that causes bubonic plague, Yersinia pestis, may have prolonged the duration of two major pandemics. They have demonstrated that modifying the copy number of a specific virulence gene increases the length of infection in affected individuals. It is thought that this genetic...
-
Document de presse | 2025.05.29
Revelations on the History of Leprosy in the Americas
Leprosy existed in America long before the arrival of Europeans: a new study reveals the history of a neglected pathogen.Long considered a disease brought to the Americas by European colonizers, leprosy may actually have a much older history on the American continent. Scientists from the Institut Pasteur, the CNRS, and the University of Colorado (USA), in collaboration with various institutions...
-
Vidéo | 2025.06.10
Avian flu: should we be worried?
Avian flu is all over the news... but what is the real risk to humans?Marie-Anne Welti, head of the Molecular Mechanisms of Pneumovirus Multiplication unit at the Institut Pasteur, takes stock of the current situation.The H5N1 virus, responsible for avian flu, mainly affects birds, but has also been detected in farmed mammals, such as dairy cows in the USA since 2024.In France, cases were...
